- Concentration: 2.5% Lincomycin (25 mg/ml)
- Volume: 5ml or 10ml per bottle
- Packaging: Sterile plastic dropper bottle, 1 bottle/box
- Shelf Life: 24 months (unopened)
Package:
Product Description
2.5% Lincomycin Hydrochloride Eye Drops 10mL: What the Published Guidance Says
Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.
This page collects the supply-relevant facts for 2.5% Lincomycin Hydrochloride Eye Drops 10mL — specification, testing, packaging and the registration paperwork that travels with the batch.
- Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
- Evidence for conjunctivitis does not favour one antibiotic over another The Committee noted that topical antibiotics are indicated for moderate to severe infection and can be considered in mild cases, but that available evidence does not make it possible to identify specific, preferred antibiotics for conjunctivitis. It therefore endorsed the existing gentamicin and tetracycline listings rather than picking a winner. WHO eEML — Ofloxacin (ophthalmological)
- Ofloxacin 0.3% — for keratitis, and extended to conjunctivitis Ofloxacin eye drops 0.3% are listed for infectious keratitis, and in 2021 the Expert Committee recommended expanding the indication to include conjunctivitis. Topical fluoroquinolones are the class the Committee endorsed for infectious keratitis. WHO eEML — Ofloxacin (ophthalmological)
Each point above is reproduced because it has a practical consequence for 2.5% Lincomycin Hydrochloride Eye Drops 10mL: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.
Ordering Parameters for 2.5% Lincomycin Hydrochloride Eye Drops 10mL
| Product Name | 2.5% Lincomycin Hydrochloride Eye Drops 10mL (Lincomycin HCl Ophthalmic Solution) |
| Specification | 10mL sterile eye drops containing 2.5% (25 mg/mL) Lincomycin Hydrochloride |
| Dosage Form | Sterile Ophthalmic Solution (Eye Drops — for topical ocular administration) |
| Active Ingredient | Lincomycin Hydrochloride (Lincosamide Antibacterial Agent) |
| Pharmacological Class | Antibacterial Ophthalmic Agent (Lincosamide) |
| Route of Administration | Topical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 2-4 hours initially, then reduced as directed. |
| Storage | Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening. |
| Therapeutic group | Ophthalmic — Ophthalmic |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL, 5% Taurine Eye Drops 10mL, 1% Acyclovir Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.3% Gentamicin Eye Drops 10mL, 0.5% Hypromellose Eye Drops 10mL, 0.5% Kanamycin Eye Drops 10mL, 0.5% Moxifloxacin Hydrochloride Eye Drops 10mL.
Pharmacopoeial Standard, Release Testing & COA
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Release testing for 2.5% Lincomycin Hydrochloride Eye Drops 10mL follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The quality control package for the marketed pack covers:
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packing, Labelling Languages & Export Paperwork
- Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
- Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Marketing Authorisation & Tender Support
The legal manufacturer named on every document for 2.5% Lincomycin Hydrochloride Eye Drops 10mL is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
2.5% Lincomycin Hydrochloride Eye Drops 10mL is presented here against ophthalmic preparations used in WHO and MSF eye-care protocols. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.
2.5% Lincomycin Hydrochloride Eye Drops 10mL: Common Procurement Questions
What pack size is available for 2.5% Lincomycin Hydrochloride Eye Drops 10mL?
Standard commercial packaging for this line is Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.
What documentation comes with a shipment of 2.5% Lincomycin Hydrochloride Eye Drops 10mL?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening.
Does the batch documentation for 2.5% Lincomycin Hydrochloride Eye Drops 10mL support a registration filing?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
What documentation accompanies an ophthalmic order?
Batch COA covering assay, sterility and preservative content, plus stability data, DMF and dossier packages with registration support documents.
Which ophthalmic anti-infectives are on the WHO Model List?
Gentamicin eye drops 0.3% (for infectious blepharitis) and ofloxacin eye drops 0.3% (infectious keratitis, with the indication extended to conjunctivitis in 2021). Amikacin, kanamycin, netilmicin and tobramycin are specified as therapeutic alternatives to gentamicin.
Products Commonly Ordered with 2.5% Lincomycin Hydrochloride Eye Drops 10mL
- 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL — 10mL
- 5% Taurine Eye Drops 10mL — 10mL
- 1% Acyclovir Eye Drops 10mL — 10mL
- 0.5% Chloramphenicol Eye Drops 10mL — 10mL
- 0.3% Gentamicin Eye Drops 10mL — 10mL
- 0.5% Hypromellose Eye Drops 10mL — 10mL
Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.
Request a Quotation for 2.5% Lincomycin Hydrochloride Eye Drops 10mL
Tell us the monograph, pack size and quantity required for 2.5% Lincomycin Hydrochloride Eye Drops 10mL 10mL, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
